Zinc gluconate
As of the edition of 20 October 2026, Zinc gluconate is a small molecule: marketed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Brand name
- Addel Junior
- Approvals on record
- 16 in 16 regions
- Holder of the most recent approval
- Laboratoire Aguettant; 3 holders in all
- Registered trials
- 14, 0 stopped early
- Disease areas
- Nervous system; Digestive system; Cancer; Lungs and airways; Nutrition and metabolism; Ear, nose and throat
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 1 | 0 | 0 |
| Phase 1 | 3 | 1 | 0 | 0 |
| Phase 2 | 4 | 3 | 1 | 0 |
| Phase 3 | 3 | 2 | 0 | 0 |
| Phase 4 | 2 | 0 | 1 | 0 |
| All trials | 14 |